The Vonoprazan Fumarate API Market Research underscores the critical role of innovation in shaping clinical outcomes and market dynamics. Potassium-competitive acid blockers are preferred for GERD, peptic ulcers, and H. pylori eradication due to their rapid action and effectiveness. Oral dosage forms dominate the market, while ongoing research focuses on optimizing bioavailability, reducing...